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Amniocentesis is the most common invasive procedure performed during pregnancy
(Eddleman, et al., 2006). One important factor that women consider when making a decision
about amniocentesis is the risk of miscarriage associated with the procedure. People use
heuristics such as anchoring, the action of using a prior belief regarding the magnitude of risk
as a frame of reference for new information to be synthesized, to better understand risks that
they encounter in their lives. This study aimed to determine a woman’s perception of
miscarriage risk associated with amniocentesis before and after a genetic counseling session
and to determine what factors are most likely to anchor a woman’s perception of miscarriage
risk associated with amniocentesis. Most women perceived the risk as low or average precounseling and were likely to indicate the numeric risk of amniocentesis as <1% risk. A
higher percentage of patients correctly identified the numeric risk as <1% post-counseling
when compared to pre-counseling. However, the majority of patients’ feeling about the risk
perception did not change after the genetic counseling session (60%), regardless of how they
perceived the risk before discussing amniocentesis with a genetic counselor. Those whose
risk perception did change after discussing amniocentesis with a genetic counselor showed a
decreased risk perception (p<0.0001). Of the multitude of factors studied, only two showed
significance: having a friend or relative with a personal or family history of a genetic
disorder was associated with a lower risk perception (p=0.001) and having a child already

was associated with a lower risk perception (p=0.038). The lack of significant factors may
reflect the uniqueness of each patient’s heuristic framework and reinforces the importance of
genetic counseling to elucidate individual concerns.
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BACKGROUND
Prenatal diagnostic procedures provide insight about fetal health and have become
routine in obstetrical practice. These procedures provide information about the genetic,
biochemical, and physiological constitution of the fetus (Eisenberg & Wapner, 2002).
Amniocentesis is the most common invasive procedure performed during pregnancy
(Eddleman, et al., 2006). While amniocentesis may be routine, there are several complex
aspects of the procedure that are explained to women prior to invasive testing (Hunt, de
Voogd, & Castendeda, 2005). One important factor that women consider is the risk of
miscarriage associated with amniocentesis.

History and Application of Amniocentesis
In 1956, Fuchs and Riis first described the potential predictive use of the analysis of
amniotic fluid. Researchers collected amniotic fluid after membrane rupture to induce labor.
At this point in history, the usual indications for amniocentesis were therapeutic purposes
such as reducing amniotic fluid in pregnancies affected by polyhydramnios (Woo, 2007), but
not for diagnostic reasons. This fluid was analyzed to determine whether Barr bodies could
be detected in amniocytes present in the amniotic fluid. The ultimate goal of the research was
to propose a method for determining fetal sex before birth (Fuchs & Riis, 1956).
Currently, amniocentesis is the most common invasive procedure used during
pregnancy to detect genetic abnormalities (Eddleman, et al, 2006). Genetic amniocentesis
determines fetal karyotype and the amount of amniotic fluid alpha-fetoprotein (AFP).
Amniocentesis can be performed from around 15 weeks of gestation until the end of the
pregnancy (Kirkham, Harris, & Grzybowski, 2005) and is performed under direct ultrasound
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guidance using a 20- or 22-gauge spinal needle. Ultrasound is utilized to identify a pocket of
fluid away from the fetus after which the spinal needle is inserted through the maternal
abdomen and uterus into the amniotic fluid sac. Approximately 20 cc of amniotic fluid is
withdrawn and sent for analysis. Fetal cells floating within the amniotic fluid sample are
grown in tissue culture and karyotyped to determine the presence or absence of a
chromosome problem (Eisenberg & Wapner, 2002). While the usual focus of amniocentesis
is to diagnose chromosomal abnormalities, additional indications include measurement of
AFP for prediction of open neural tube defects, analysis for single gene disorders,
determination of the presence of infection, and determination of fetal lung maturity (Woo,
2007).
As more clinicians began performing amniocentesis, the methodology evolved. In
1985 Romero et. al. compared two different ways of performing amniocentesis procedure.
One method, called the sonographically-guided technique, involved the clinician using an
ultrasound transducer to locate an appropriate area of fluid to sample, removing the
transducer, and inserting the needle in the selected position. A second method, called
sonographically-monitored technique, consisted of continuous ultrasound visualization of the
fluid pocket throughout the procedure. The study determined that when the sonographicallyguided technique was applied, 5.2% of the procedures resulted in a bloody tap and 7.7%
resulted in a dry tap. In comparison, use of the sonographically-monitored technique resulted
in 1.2% of these procedures with a bloody tap and 2.0% of these procedures with a dry tap.
The differences were statistically significant (Romero, et al., 1985). Following these findings,
many centers began using the sonographically-monitored technique as standard practice
(Woo, 2007).
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As with any invasive procedure, amniocentesis is associated with risks to the patient
and fetus. Risks include complications that could potentially lead to miscarriage, such as
amniotic fluid leakage, spotting, cramping, and infection (Eisenberg & Wapner, 2002).
Studies evaluating the risk of a spontaneous abortion associated with amniocentesis have had
varying results.

Miscarriage Risk Associated with Amniocentesis
In the 1970s, studies began to emerge describing the risk for miscarriage with
amniocentesis. Philip and Bang (1978) reported on data gathered from 1177 pregnant women
who underwent amniocentesis. Of the women sampled, 28 (2.4%) women experienced a
spontaneous abortion. The authors reported that about 25% of the women who experienced
spontaneous abortion underwent the procedure prior to 16 weeks of gestation. Investigators
also noted that 11 of the 28 women “were probably already at risk of aborting” (Philip &
Bang, 1978, p. 1184) based on a variety of factors, including bleeding, cervical insufficiency,
and abnormalities of the placenta. Of the remaining women who experienced a spontaneous
abortion, 8 (0.70%) women had their first symptom of a miscarriage within three weeks of
undergoing the procedure. If three weeks following the procedure is considered to be the
time for a miscarriage to occur, then the authors felt that a miscarriage risk of 0.70% should
be quoted to women considering amniocentesis. Three women (0.25%) experienced a
spontaneous abortion within one week of the procedure. If one week is considered a
reasonable time period for miscarriage risk, then the authors concluded that 0.25% risk
should be quoted to pregnant women considering amniocentesis. Thus the authors reported
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the miscarriage rate associated with amniocentesis as 0.3-0.7%. In this particular study, there
was no control group (Philip & Bang, 1978).
An investigational group in Canada also studied the pregnancy loss rate associated
with amniocentesis. This study examined 1223 amniocenteses performed on 990 pregnant
women with 1020 pregnancies. Thirty women had amniocenteses performed in two different
pregnancies occurring during the time period of the study. The control group consisted of
data gathered from vital statistics records from different national organizations in Canada on
spontaneous abortions between 16 and 19 weeks gestation at several hospitals in Toronto and
other Canadian cities. Demographic data was available on all pregnant women in the control
group. The investigators reported that the incidence of fetal loss after amniocentesis was
4.7%, which was not statistically different from the loss rate in the control group of 9164
pregnant women (5.6% and 3.7% miscarriage rates at the two hospitals compared to the
study group). The researchers concluded that the amniocentesis is a safe procedure for both
the mother and the fetus (Simpson, et al., 1976).
Niermeijer et. al. performed a study that followed 350 pregnant women 38 years of
age or older who underwent amniocentesis between 14 and 16 weeks of gestation (1976).
Three experienced a spontaneous abortion within one month following the procedure. Of
these three cases, one of the procedures was performed transvaginally due to placental
location, one fetus was at risk for Pompe disease (showed deficiency of α-1,4-glucosidase
activity), and one fetus was conceived by a mother with a balanced translocation (the fetal
cells failed to grow and were not available for analysis). Based on these considerations and
other analyses in the study, the authors concluded that the miscarriage risk associated with
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amniocentesis was ± 1% (Niermeijer, Sachs, Jahodova, Tichelaar-Klepper, Kleijer, &
Galjaard, 1976).
Several other studies have indicated a variety of miscarriage rates associated with
amniocentesis. In 1986, one of the few randomized trials pertaining to amniocentesis was
conducted. The authors found a miscarriage rate of 1.7% among the group that underwent the
amniocentesis versus a 0.7% miscarriage rate in the control group. The rate of miscarriage
among the study group was significantly higher than the control group (Tabor, Madsen, Obel,
Philip, Bang, & Norgaard-Pedersen, 1986). Subsequent studies have shown risks ranging
from 0.3% to 0.5%, (Leschot, Verjaal, & Treffers, 1985; Blessed, Lacoste, & Welch, 2001).
In 1995 the Centers for Disease Control and Prevention (CDC) released a statement
that reported the risk of miscarriage after amniocentesis to be between 0.25% and 0.5%. This
risk number was not calculated from a study or publication; rather, a committee at the CDC
reviewed many different publications that described the miscarriage risk associated with
amniocentesis and determined a risk number that seemed appropriate to the committee. This
risk became generalized as the 1 in 200 risk routinely quoted with amniocentesis (Olney,
Moore, Khoury, Erickson, Edmonds, & Botto, 1995).
Mujezinovic and Alfirevic (2007) conducted a review of the literature on the risk of
miscarriage associated with amniocentesis and analyzed various risk figures quoted by
previous studies. Twenty-nine studies were found to meet criteria for analysis. After dividing
the findings of these studies into larger groups for analysis, authors concluded that the risk
for pregnancy loss within 14 days of the procedure was 0.6%, the risk for loss of pregnancy
before 24 weeks gestation was 0.9%, and the total pregnancy loss after amniocentesis was
1.9%. The investigators noted that only five of the studies analyzed included control groups.
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Therefore these numbers do not take into account the background risk for miscarriage
(Mujezinovic & Alefirevic, 2007).
In 2007, the American College of Obstetricians and Gynecologists (ACOG) issued a
practice bulletin summarizing the miscarriage rate associated with amniocentesis after
reviewing several studies on the subject (ACOG Practice Bulletin No. 88: Invasive Prenatal
Testing for Aneuploidy, 2007). The committee summarized the miscarriage rate associated
with amniocentesis as 1/300-1/500. This range of risk figures attempted to capture the
breadth of miscarriage loss rates as quoted by various studies. This conclusion was based on
“limited or inconsistent scientific evidence” (ACOG Practice Bulletin No. 88: Invasive
Prenatal Testing for Aneuploidy, 2007, p. 1465), indicating that previous studies that
examined the amniocentesis-associated miscarriage rate produced conflicting information
regarding the exact risk figure.
Researchers stated the need to assess the miscarriage rate associated with
amniocentesis using data collected in a large prospective study. The First and Second
Trimester Evaluation of Risk (FASTER) trial was a large multi-center study that compared
first trimester and second trimester screening techniques for the detection of Down
syndrome. The trial collected data from over 35,000 pregnant women in the United States. In
addition to investigating screening efficacy, data from women who chose to undergo an
amniocentesis after screening were collected and compared to women in the trial who did not
undergo an amniocentesis. This study found that the loss rate in the amniocentesis group was
1/1600 or 0.006% higher than controls. This risk of miscarriage associated with
amniocentesis was therefore concluded to be much lower than previously estimated
(Eddleman, et al., 2006).
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In response to the data published from the FASTER trial, Alfirevic and Tabor
published a letter to the editor voicing concerns regarding several of the procedures carried
out during the study (2007). Afirevic and Tabor commented on the lack of data regarding the
gauge of the needle used during the amniocentesis. Concerns were raised about the control
group used in the FASTER trial: according to their reading of the study, the control group
contained every case of pregnancy loss up to 24 weeks gestation and did not specify the
gestational week each pregnancy loss occurred (Alfirevic & Tabor, 2007). Alfirevic and
Tabor commented that individuals in the control group could not be adequately matched to
individuals who pursued the amniocentesis. The major investigators of the FASTER trial
amniocentesis study replied to these concerns, stating that an informal poll of many of the
investigators involved in the trial found that a majority of procedures were performed using a
22-gauge needle. In addition, the FASTER trial investigators claimed that the second
statement by Alfirevic and Tabor was incorrect because each of the participants included in
the analysis was required to complete the entire protocol (all women had a second trimester
blood draw after 15 weeks of gestation). Therefore the patients had to be pregnant at least
through 15 weeks and thus the analysis did not include first trimester losses. The trial
included women who experienced pregnancy loss between gestational weeks 15 and 24,
which was the time period in which the study group experienced pregnancy loss (Eddleman
& Malone, 2007).
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Screening for Aneuploidy
In the United States, the main indication for discussion of amniocentesis has
historically been advanced maternal age, or a woman who is age 35 years or greater at the
time of delivery. The rationale for this indication stems from the increased likelihood of
women with advanced age to have a child with a chromosomal abnormality, such as Down
syndrome (ACOG Practice Bulletin No. 77: Screening for Fetal Chromosomal
Abnormalities, 2007). More recently, ACOG recommended that amniocentesis be offered to
all pregnant women, regardless of age. This change was made because women at any age can
have a child with a chromosomal abnormality (ACOG Practice Bulletin No. 88: Invasive
Prenatal Testing for Aneuploidy, 2007).
Modern non-invasive screening focuses on biochemical markers in maternal blood
that can be used to alter the a priori risk of aneuploidy. There are several screening options
available during pregnancy to aid in the determination of a woman’s risk for having a child
with a karyotypic abnormality or structural fetal anomaly. An example of a screening
technique is ultrasound, which examines the physical structures of the fetus to assess for birth
defects. If a fetus has Down syndrome, soft markers or fetal abnormalities may be identified
by ultrasound. However, not every pregnancy affected with Down syndrome will have soft
markers or structural abnormalities. Prior studies describe that sonographic markers or
abnormalities are detected in approximately 30-50% of fetuses with Down syndrome
(Rotmensch, et al., 1997; Benacerraf B., 2000).
Another screening method commonly utilized is second trimester maternal serum
screening, which measures the levels of various metabolites between fourteen and twentyone gestational weeks of pregnancy. Quadruple screening refers to the examination of alpha-
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fetoprotein (AFP), human chorionic gonadotropin (hCG), unconjugated estriol (uE3), and
inhibin A (DIA) in the mother’s blood. Second trimester maternal serum screening is the
most common screening method for Down syndrome in the United States (Malone, et al,
2005). Approximately 80% of affected fetuses are detected using the quadruple screen
(ACOG Practice Bulletin No. 77: Screening for Fetal Chromosomal Abnormalities, 2007).
The screening method that has been utilized in more recent years is first trimester
screening, which can be performed between eleven and thirteen weeks of gestation. First
trimester screening involves obtaining a nuchal translucency measurement of the fluid behind
the fetal neck as well as an analysis of the analytes free or total β-hCG and pregnancyassociated plasma protein A (PAPP-A). The first trimester screen detects approximately 8287% of all fetuses with Down syndrome, which is a higher detection rate than second
trimester screening. One major advantage of the first trimester screening method is that
women receive information about their risk to have an affected pregnancy at an early stage of
gestation (ACOG Practice Bulletin No. 77: Screening for Fetal Chromosomal Abnormalities,
2007).

Conflicting Goals of Amniocentesis
Most practicing health care professionals who render obtetrical care view
amniocentesis as a routine but invasive procedure. However, a study performed by Hunt, de
Voogd, and Castendeda (2005) revealed that, while health care professionals may view
prenatal screening and diagnostics as routine, pregnant women faced with the decision about
whether or not to proceed with this testing do not see the procedures as routine. Hunt
examined the interactions between pregnant women and their physicians discussing the
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results of their maternal serum screening test and information regarding the amniocentesis.
The study found that the health care professionals and patients had drastically conflicting
views of the purpose and motivations for proceeding with the amniocentesis. Clinicians
viewed the decision to proceed with amniocentesis as part of an isolated medical algorithm in
which very little consideration was given to the patient’s personal life or experiences. In
contrast, the patients viewed the amniocentesis as a way to assure themselves that everything
in their pregnancy is normal (Hunt, de Voogd, & Castendeda, 2005). The study emphasized
the stark contrast between patient and clinician motivation for prenatal screening and
diagnositcs; while both parties claim that these tests promote a healthy pregnancy, it became
clear in the course of the study that the motivations for using these tests to achieve the goals
mentioned above were very different. The authors commented that clinicians viewed prenatal
screening and diagnostic testing as routine and mundane because these tests were often
performed in the clinican’s office. The patients who were undergoing these screening and
diagnostic procedures viewed them as momentous and often frightening. These differences in
viewpoint may be accounted for by considering various heurstics, or risk assessments, that
are associated with decision making.

Risk Perception
When an individual evaluates risk, empirical data describing the incidence of the
event being evaluated is rarely available to them; rather, individuals usually rely on other
means to judge the riskiness of a situation. This risk judgment is known as a heuristic. While
simplification of the understanding of risk can be useful in everyday situations, it consistently
leads to misjudgments regarding the severity of risk. The way a risk is perceived can be
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altered by many factors, including the individual’s personal experience with an event or how
familiar an individual is with the frequency of an event occurring (Slovic, Fischhoff, &
Lichtenstein, Rating the Risk, 2000).
Risk perception has been studied in a variety of fields, including geography,
anthropology, and political science. Research in the domain of psychology has evaluated how
individuals utilize heuristics to evaluate risk in their life. Factors such as level of
understanding of a risk and biases incorporated from outside sources affect how a person
perceives risk (Slovic, The Perception of Risk, 2000).

Anchoring, Representativeness, and Availability
Amos Tversky and Daniel Kahneman introduced the concepts of anchoring,
representativeness, and availability in relation to the methodology that a person uses to
perceive risk (1974). These concepts are specific examples of heuristics that can be used by
an individual to better understand risks that they encounter in their lives.
Representativeness describes the situation in which an outcome is assumed to result
from a process and the individual making the assumption holds to a set of restrictions that the
individual believes to be true. It is also described as a type of correlation-causation
assumption; the more often a person experiences event A with event B, the more an
individual judges events A and B to be related to each other or for one to be caused by the
other. Representativeness can bias an individual to perceive the riskiness of an event to be the
same irrespective of the sample size being considered (Tversky & Kahneman, 1974). For
example, if a woman knows three acquaintances that have undergone amniocentesis and one
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of them miscarries, she may perceive the risk of miscarriage due to amniocentesis to be one
in three when in reality the risk is much smaller.
Availability describes how perception is altered by how easily an event comes to
mind. For example, if you asked a middle-aged individual the frequency of a heart attack in
the population, they use examples that they can recall from their own experiences and
acquaintances to report a probability. Thus, a person’s perception of the risk or probability
that an event will occur is influenced by their personal experiences and how easily they can
recall examples in their own lives (Tversky & Kahneman, 1974). Whenever an event is easy
to imagine or recall, it creates the perception that the event occurs at a greater frequency than
what empiric data support (Slovic, Fischhoff, & Lichtenstein, Cognitive Processes and
Societal Risk Taking, 2000).
Anchoring describes the situation when a person estimates a risk value by first
considering an initial value (whether correct or not) and adjusting that risk using a variety of
judgments to result in a final answer. In this heuristic, prior understandings of a given risk
will ultimately lead to an estimate that is biased towards the initial value. Two avenues
influence the final risk: the starting risk and the adjustments that are made during the
evaluation process that produces the final risk calculation (Tversky & Kahneman, 1974).
Research in this area indicates that when an individual makes a judgment about a risk, the
adjustments tend to be crude and haphazard. Individuals may not consider the full
implications of the new information or they may over- or underestimate the importance of the
new information that is being incorporated in their final risk perception (Slovic, Fischhoff, &
Lichtenstein, Cognitive Processes and Societal Risk Taking, 2000).
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Representativeness, availability, and anchoring all play a role in risk perception and
probability calculation in a wide variety of contexts and applications. While these factors are
predictably seen in both everyday existence and in formal research, they inevitably lead to
errors that affect the ways in which a person perceives and evaluates risk. This fact is
important to consider in clinical applications in which risk perception plays a role (Slovic,
The Perception of Risk, 2000).

Risk Perception and Genetic Counseling
The CDC statement addressing the miscarriage rate associated with amniocentesis
acknowledged the complexity of the decision to proceed with invasive prenatal diagnostic
testing (Olney, Moore, Khoury, Erickson, Edmonds, & Botto, 1995). In its statement, the
committee urged health care professionals to discuss the various aspects of this decision with
patients, including maternal age and family history. The statement also recommended that the
benefits, risks, and limitations of amniocentesis be discussed in depth with patients so that
each pregnant woman has the adequate knowledge necessary to make an informed decision
regarding prenatal diagnosis (Olney, Moore, Khoury, Erickson, Edmonds, & Botto, 1995).
Although the committee’s task was to empirically assess the miscarriage rate associated with
prenatal diagnostic procedures, it also emphasized the importance of taking all factors into
consideration before proceeding with an invasive prenatal procedure. This statement
acknowledged that a decision regarding a potentially devastating outcome for a pregnant
woman should be weighed against other factors besides the simple empiric risk of
miscarriage associated with the procedure (Olney, Moore, Khoury, Erickson, Edmonds, &
Botto, 1995).
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A recent study by Stevens et. al. (2008) investigated whether women perceived a
difference between a range of risk figures associated with amniocentesis. This study
attempted to determine which factors influence risk perception the most and at what risk
level women were most comfortable with proceeding with an amniocentesis. In addition,
Stevens et. al. examined a variety of factors that have the potential to influence a woman’s
perception of miscarriage risk associated with amniocentesis including parity, utilization of
maternal serum screening, and previous children born with a birth defect. Stevens found that
participants did interpret the range of risk figures as different and were more likely to wish to
proceed with an amniocentesis when the risk of miscarriage was quoted at a lower figure.
Additionally, none of the demographic factors were significantly associated with an
amniocentesis decision. This study highlighted the concept that the quoted miscarriage risk
figure is an important part of the decision-making process regarding the uptake of
amniocentesis. However, Stevens et. al. noted that by placing all of the risk figures together,
the participants may have been anchored to the lowest risk of miscarriage quoted. The
majority of participants generally understood which risk figure was lowest and thus may
have been influenced to select the lowest choice because they were comparing it to higher
risks. The authors suggest that further study is needed to determine how women perceive
various miscarriage risks associated with amniocentesis without being influenced by a range
of figures.

Anchoring and Risk Perception Associated with Amniocentesis
Although there is a quantitative risk for miscarriage with amniocentesis, this
information may not be the only factor that influences a woman’s perception of the
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miscarriage risk. Anchoring, or the prior perception that serves as the frame of reference for
new information, may have a great impact on the perception of risk. For women who
participate in a prenatal discussion regarding amniocentesis and miscarriage risk, anchoring
may have a profound impact on their risk perception that is independent of the numeric risk
quoted by a genetic counselor or physician. A woman’s previous experience with
amniocentesis or the experiences of individuals whom she knows may serve as the frame of
reference for her perception of the miscarriage risk. To date, no study has specifically
examined the influence that anchoring effects have on the perception of miscarriage risk
associated with the amniocentesis. Therefore, this study aims to determine what factors are
most likely to anchor a woman’s perception of miscarriage risk associated with
amniocentesis and to determine a woman’s perception of miscarriage risk associated with
amniocentesis before and after a genetic counseling session. This information may help both
physicians and genetic counselors alike to better understand the influence that previous
perceptions regarding the miscarriage risk have on the uptake of amniocentesis.
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MATERIALS AND METHODS
Study Recruitment
Surveys were offered to pregnant women who were attending prenatal appointments
at a University of Texas affiliated high-risk pregnancy clinic and met eligibility
requirements. In order to be eligible, the patient’s indication had to involve the possibility of
having an amniocentesis performed and included advanced maternal age and abnormal serum
screen results. Patients were eligible to participate if they were also at least 18 years of age,
spoke English, and were being seen at an IRB approved satellite clinic in the Houston, Texas
area associated with the University of Texas Medical School at Houston, Department of
Obstetrics, Gynecology, and Reproductive Sciences Division of Maternal Fetal Medicine:
University of Texas Professional Building, Memorial Hermann Memorial City, Memorial
Hermann Katy, Memorial Hermann Southeast, Memorial Hermann Southwest, and Memorial
Hermann Sugar Land. A letter of invitation was given to eligible women. Those who chose
to participate completed a two-part anonymous survey. Participants were recruited from
September 14, 2009 to February 12, 2010.

Survey Instrument
An anonymous survey was developed to assess women’s attitudes and perceptions
about the miscarriage risk associated with amniocentesis. The survey was divided into three
major portions. Each survey had a unique identifying number that was written onto each
portion in order to match them during data analysis. The first portion was given to women
while they waited for their genetic counseling appointment and provided a brief description
of the amniocentesis and asked women about their perception of the miscarriage risk
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associated with amniocentesis, including questions that asked women to quantify the risk of
miscarriage and rate their feelings about this risk (see Appendix A). The first portion also
requested information about the participant’s personal history, medical history, pregnancy
history, and personal experience with various friends and family members who may have a
genetic disorder. The second portion of the survey was administered after the genetic
counseling session and asked participants to again quantify the risk of miscarriage associated
with the amniocentesis and rate their feelings about the riskiness of the procedure (see
Appendix B). This portion also asked women whether or not they were planning to undergo
the amniocentesis and asked them to explain the reasons for their decision. The third portion
of the survey was completed by the genetic counselor after the counseling session (see
Appendix C). This portion asked the counselor to identify the various factors that they
believed influenced the patient’s decision whether or not to proceed with the amniocentesis.
The counselor also provided pregnancy history information about the patient.
The protocol was submitted to the institutional review board of the University of
Texas Health Science Center Memorial Hermann Healthcare System and approved via
expedited review (UT IRB HSC-MS-09-0365).

Survey Administration
A letter of invitation was given to eligible women when they arrived at the clinic (see
Appendix D). When the patient elected to participate and completed the first portion of the
survey, the front desk personnel placed the letter of invitation into the patient’s chart so that
the genetic counselor would be aware that the patient had completed a survey. The completed
survey section was placed in a separate collection box. This method ensured that the
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counselor would not be biased by the patient’s responses on the first portion of the survey.
The letter of invitation was given back to the participant after the completion of the genetic
counseling session if requested so that the participant could have more information about the
study. After the counseling session was completed, the counselor led the patient to the
waiting room and gave the patient the second portion of the survey. While the patient waited
for their ultrasound, they completed the second portion of the survey. The second portion was
collected by the front desk personnel or ultrasonographer. The third portion of the survey was
completed by the counselor after the session. Survey portions were later matched by their
unique identifying number.

Statistical Analysis
The survey response fields were coded and data was entered into a Microsoft Excel
spreadsheet. Statistical analysis was performed using STATA software. Information coding
for the numeric risk figure before and after counseling was converted from proportion out of
1000 to a percentage. These percentages were used in all subsequent analysis evaluating
differences in risk quantification. Distribution of demographic variables (race, education,
income, and religion) was described.
The perception of risk before counseling and after counseling was evaluated with
respect to various factors including personal experience with amniocentesis, having a friend
or relative with a genetic disease, and pregnancy information. Contingency tests were used to
evaluate the differences in frequencies of each risk perception category for all the above
factors.
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Changes in risk perception from before to after counseling were also calculated.
Wilcoxon signed rank test was used to compare the magnitude and direction of these changes
after stratification by the factors mentioned above.
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RESULTS
Data was gathered via surveys that were administered in three main sections. The first
two sections of the survey were completed by the patient and the third section was completed
by the genetic counselor following the session. One hundred thirteen first sections, 104
second sections, and 110 third sections were returned. Ninety-nine surveys had all three
sections completed.
It will be noted in several of the following tables and figures that not every question
was completed by every participant, thereby making the sample size of certain tables smaller
than the sample sizes noted above. All percentages reflect the number of participants who
chose an answer out of the total for a given question. In addition, whenever comparisons
were made between risk perception and a given factor, the sample size noted represents those
who answered both the perception question and the question about the given factor.

Demographics
Participants were asked to indicate their race (Table 1), education level (Table 2),
total household income (Table 3), and religion (Table 4a). All those who indicated their
religion as “other” had the opportunity to write a description of their religion. Forty-one of 49
participants who checked “other” and wrote a description indicated items such as
“Christian,” “Baptist,” or “Methodist,” which were all grouped together under Protestantism.
One participant indicated that her religion was “Catholic/Jewish.” Six participants left the
field blank, and 1 wrote “n/a”. These 7 participants were grouped together in the category
“Other” while the 41 non-Catholic Christian denominations were grouped in the category
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Protestant. Therefore the actual percentage of participants who were Protestant was 51.88%
(Table 4b). The groupings in Table 4b were used in future comparisons.
Table 1. Demographics: Race
Race

n=111

Percent

AA

27

24.32%

Hispanic

29

26.13%

Asian

10

9.01%

Caucasian

39

35.14%

Other

6

5.41%

Table 2. Demographics: Education
Education

n=111

Percent

Some HS

8

7.21%

HS

25

22.52%

Some College

29

26.13%

College

34

30.63%

Grad School

15

13.51%
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Table 3. Demographics: Income
Annual Income n=100

Percent

<$30K

34

34%

$30-60K

27

27%

$60-100K

16

16%

>$100K

23

23%

Table 4a. Demographics: Religion
Religion

n=106

Percent

Protestant 14

13.21%

Catholic

27

25.47%

Jewish

1

0.94%

Muslim

4

3.77%

Buddhist

1

0.94%

Hindu

3

2.83%

None

7

6.6%

Other

49

46.23%
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Table 4b: Demographics: Religion Revised
Religion

n=106 Percent

Protestant

55

51.88%

Catholic

27

25.47%

Jewish

1

0.94%

Muslim

4

3.77%

Buddhist

1

0.94%

Hindu

3

2.83%

None

7

6.60%

Other (blank)

7

6.60%

Other (non-

1

0.01%

Protestant)

Miscarriage Risk Quantification Before Counseling
Before the genetic counseling session, patients were given the opportunity to indicate
how many women out of 1000 they believed would miscarry following the amniocentesis or,
if the patient preferred, to indicated the percentage of women who would miscarry following
an amniocentesis. Twenty-six total responses were indicated on the first portion of the survey
for the miscarriage number and 29 total responses were recorded for the percentage of
women who would miscarry due to the amniocentesis. Patients provided a wide variety of
responses. Lists of responses are in Tables 5 and 6.
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Table 5. Numeric Risk Before Counseling
Number/1000 n=26
0

1

1

7

2

2

2-3

2

3

1

5

3

10

1

15

1

20

4

50

1

100

2

250

1
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Table 6. Percentage Risk Before Counseling
Percent

n=29

0

1

0.003

1

<1/2

1

0.5

1

1

5

1-2

2

2

5

3

3

4

1

5

4

7

1

10

1

25

1

40

1

60

1

In order to simplify the examination of the quantification of miscarriage risk
perception before counseling, all of the responses given in numerical form were converted to
percentages and combined with the data of participants who answered the question in
percentage form. Ranges of these percentages were formed for ease of analysis. In the first
portion of the survey, 8 participants answered with both a number and a percentage. Both
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number and percentage values are reflected in Tables 5 and 6. However, only the percentage
values were used in the data in Figure 1, which examines general trends of risk quantification
before counseling. Figure 1 shows that most of the participants (n=27) believed the risk to be
between 0-1%.

Number of Participants

Figure 1. Miscarriage Risk Quantif
Quantification
ication Before Counseling (Percentage Form)

30

27
(57.4%)

25
20
15
10
5

8
7
(17.0%) 2
(14.9%)
1
1
1
(4.3%)(2.1%) (2.1%) (2.1%)

0

0

0

Ranges of Percentages

n = 47

Miscarriage Risk Perception Before Genetic Counseling and Various Factors
Seventy-four
four participants indicated their perception of the risk of miscarriage
associated with amniocentesis before counselin
counseling
g in Likert scale format. In general, most
patients perceived the risk as low or average (Figure 2).
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Figure 2. Perception of Miscarriage Risk Before Counseling

20
(27.0%)

Number of Participants

25
20

22
(29.7%)

14
(18.9%)

11
(14.9%)

15

7
(9.5%)

10
5
0
Very Low

Low

Average

High

Very High

Miscarriage Risk Perception

n = 74

Responses were analyzed using Chi
Chi-square
square analysis to compare miscarriage risk
perception
eption and individual factors that are potentially involved in anchoring. All of the
comparisons performed were between participants who indicated a given answer and those
who did not indicate that answer. All of the sample sizes indicated in the tables are
ar those who
indicated the given answer. Table 7 indicates with whom the participant had discussed
amniocentesis. Participants were able to indicate more than one person. Two factors
approached significance: discussion of amniocentesis with a coworker (p=0.
(p=0.056)
056) and if a
person made a suggestion about the amniocentesis to the patient (p=0.077). Those
participants who indicated that they had spoken with a coworker (n=13) tended to view the
risk as average, whereas those who did not indicate they had spoken wit
with
h a coworker tended
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to view the risk as low or average. A total of 60 participants completed the survey item that
assessed whether or not someone offered them a suggestion about amniocentesis. Those who
indicated that they were told not to pursue amniocentesis (n=23) tended to view the risk as
low (n=4), average (n=9), or high (n=5) those who were told to undergo amniocentesis
(n=20) tended to view the risk as very low (n=8) or low (n=7), and those who said that the
person did not give a suggestion (n=17) considered the risk as almost equally low (n=5),
average (n=5), and high (n=4).

Table 7. Comparison of Miscarriage Risk Perception Before Counseling and Patient
Discussions with Various Individuals
Comparison of Factors

n

p-value

Discuss with Doctor

51

p = 0.090

Discuss with Husband

39

p = 0.603

Discuss with Mother

20

p = 0.404

Discuss with Friend

27

p = 0.615

Discuss with Coworker

13

p = 0.056

Discuss with Sister

10

p = 0.158

Discuss with Other

7

p = 0.235

Discuss with No One

9

p = 0.175

Person made an Amnio suggestion

60

p = 0.077
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Table 8 indicates that, of the people who report having genetic counseling before,
most were seen for advanced maternal age. One participant indicated that they had had
genetic counseling but they did not mark an indication, and one participant indicated that
they had had genetic counseling in the past but indicated that they had been seen for AMA
and for “other” indication. There were no significant differences seen between women with
previous genetic counseling and those without genetic counseling.

Table 8: Comparison of Miscarriage Risk Perception Before Counseling and Personal
Experience with Genetic Counseling (GC)
Comparison of Factors

n

p-value

Patients w/ previous genetic counseling

13

p= 0.233

Previous GC for AMA

7

p= 0.341

Previous GC for Pos DS

1

p = 0.361

Previous GC for Fam Hx

1

p = 0.214

Previous GC for Other Indication

5

p = 0.548

Table 9 shows whether the way in which patients have obtained educational
information about amniocentesis influences their risk perception. Participants were asked to
indicate all sources they utilized. The majority of women who indicated they had obtained
educational information about amniocentesis indicated doing so either via a book or the
Internet. No factors were found to be statistically significant.
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Patients were asked to indicate their personal experience with a genetic disease or
birth defect and could indicate more than one response. When analyzing whether having a
personal experience with genetic disease and birth defects influences risk perception (Table
10), there was a statistically significant difference between miscarriage risk perception and
whether or not the patient had a friend, relative, or coworker with a child or a personal
history of a genetic disease (p=0.001). If a participant knew a friend, relative, or coworker
with a personal history or a child with a genetic disease (n=24), they tended to view the risk
of miscarriage as lower than those who did not know a person with this history. In looking
further at whether it mattered what type of friend or relative had the genetic condition, we
compared specific relationships to those who did not know anyone with a genetic disease
(n=47; table 10). Two specific relationships were found to be statistically significant:
knowing a friend with a genetic disease (p=0.013) and knowing another relative with a
genetic disease (p=0.025). These individuals were more likely to view the risk as low.

Table 9. Comparison of Miscarriage Risk Perception Before Counseling and
Previous Education about Amniocentesis
Comparison of Factors

n

p-value

Learned about Amnio via book

25

p = 0.753

Learned about Amnio via Pamphlet

9

p = 0.231

Learned about Amnio via Web

33

p = 0.384

Learned about Amnio via None

23

p = 0.739

Learned about Amnio via Other

5

p = 0.132
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Patients were asked to indicate their personal experience with a genetic disease or
birth defect and could indicate more than one response. Analysis was conducted to compare
respondents to all those who did not indicate the answer being analyzed. When analyzing
whether having a personal experience with genetic disease and birth defects influences risk
perception (Table 10), the only statistically significant factor was the difference between
miscarriage risk perception and whether or not the patient had a friend, relative, or coworker
with a child or a personal history of a genetic disease (p=0.001). If a participant knew a
friend, relative, or coworker with a personal history or a child with a genetic disease (n=24),
they tended to view the risk of miscarriage as lower than those who did not know a person
with this history. In looking further at whether it mattered what type of friend or relative had
a genetic condition, one factor approached significance: the patient had a friend with a
genetic disease (p=0.060). Those who have a friend with a genetic disease or a child with a
genetic disease (n=11) were more likely to view the risk as low (n=6).
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Table 10. Comparison of Miscarriage Risk Perception Before Counseling and Personal
Experience with Genetic Disease and Birth Defects
Comparison of Factors

n

p-value

Know a friend with child/personal hx
of genetic disease

24

p = 0.001

Friend genetic disease hx

11

p = 0.013

Mother genetic disease hx

1

p = 0.201

Sister genetic disease hx

1

p = 0.422

Sister in law genetic disease hx

1

p = 0.422

Another relative genetic disease hx

7

p = 0.025

Coworker genetic disease hx

2

p = 0.390

Other genetic disease hx

7

p = 0.095

Table 11 summarizes the participants’ personal experience with amniocentesis. The
sample sizes do not sum to the correct number because one participant marked that she had
not had an amniocentesis in a previous pregnancy, yet also marked that the amniocentesis
results revealed trisomy 18. Several p-values were not calculated due to small sample sizes.
No factors were found to be statistically significant.
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Table 11. Comparison of Risk Perception Before Counseling and Personal Experience
with Amniocentesis
Comparison of Factors

n

p-value

Had Amnio in Previous Pregnancy

9

p = 0.868

Previous Amnio Results were normal

5

Not calculated

Previous Amnio Results were DS

1

Not calculated

Previous Amnio Results were Tri 18

1

Not calculated

Previous Amnio results were other

3

Not calculated

2

p = 0.532

Bleeding following Amnio

1

Not calculated

Other complication following Amnio

1

Not calculated

25

p = 0.853

Friend had Amnio

19

p = 0.917

Mother had Amnio

2

p = 0.813

Sister had Amnio

1

p = 0.361

Sister in Law had Amnio

1

p = 0.603

Another family member had Amnio

3

p = 0.239

Cowork had Amnio

5

p = 0.177

Other had Amnio

2

p = 0.813

Problem shown on friend’s Amnio

3

p = 0.138

Friend had complication after Amnio

1

p = 0.521

Complications after Amnio

Friend/Relative had Amnio
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Demographic information is summarized in Table 12; no factors were found to be
statistically significant.

Table 12. Comparison of Miscarriage Risk Perception Before Counseling and
Demographics
Comparison of Factors

n

p-value

Race

74

p= 0.848

Education

74

p = 0.658

Income

69

p= 0.551

Religion

72

p = 0.645

Table 13 indicates factors involving participants’ pregnancy and family size
information. Pregnancy information was collected from the third portion of the survey that
was completed by the genetic counselor to help ensure accuracy. The sample size for each
factor represents how many data points were available for analysis, not the total number of
pregnancies. The only statistically significant factor was the number of total living children a
participant had (p=0.038). Women who had one living child (n=28) were more likely to
indicate a risk on the lower end of the range. Participants who had more than two living
children were included in the analysis, but these sample sizes were much smaller and did not
show an obvious trend.
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Table 13. Comparison of Miscarriage Risk Perception Before Counseling and
Pregnancy and Child Information (collected by genetic counselor)
Comparison of Factors

n

n=0

n=1-2

n=3+

p-value

Total pregnancies

70

0

32

38

p = 0.670

Total living children

70

15

45

10

p = 0.038

Total miscarriages

69

47

18

4

p = 0.759

Total abortions/terminations

70

54

15

3

p = 0.104

Total stillbirths

70

68

2

0

p = 0.317

Previous child with a birth defect

10

n/a

n/a

n/a

p = 0.115

Miscarriage Risk Quantification After Counseling
Participants were asked to quantify the miscarriage risk associated with amniocentesis after
they had received genetic counseling. Sixty-five total responses were recorded in the format
where the participant indicated the number of women out of 1000 and 43 total responses
were completed for the percentage of women that would miscarry because of the
amniocentesis. A list of the responses is compiled in Tables 14 and 15.

35

Table 14. Numeric Risk After Counseling
Number/1000 n=65
0

1

0.0005

1

1

11

1/3

1

1/300

4

1/500

1

10

1

100

1

2

4

20

2

3

20

3.25

1

3.3

2

3.5

3

3/100

1

30

1

300

2

4

1

5

2

50

4

6

1
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Table 15. Percentage Risk After Counseling
Percentage n=43
1/300

1

0.05

1

0.3

1

0.5

3

<1%

2

1

12

1.5

1

1.99

1

2

6

2.5

2

3

2

5

1

10

3

30

2

60

1

90

1

95.2

1

98

1

99

1
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As with the first portion of the survey, all of the responses were converted to
percentages and put into ranges for ease of comparison. For this question, 18 participants
answered both with a numeral and a percentage. In these cases, the percentage that was
indicated by the participant was used in the comparison. Figure 3 indicates that the vast
majority of patients believed that the risk was between 00-1%
1% after counseling.

Number of Participants

Figure 3. Miscarriage Risk Quanti
Quantification
fication After Counseling (Percentage Form)

70
60
50
40
30
20
10
0

66
(73%)

8
5
4
3
3
1
0
0
(9%) (6%)
(3%) (0%) (3%) (1%) (0%) (4%)

Range of Percentages

n = 90

Figure 4 illustrates the comparison of miscarriage risk quantification before and after
the counseling session. The percentage of each set of responses (before counseling and after
counseling) are indicated on the graph. Most patients, both before and after counseling,
indicated that the risk of miscarriage associated with amniocentesis was 1% or less. There is
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a statistically significant difference between risk quantification before and after counseling
coun
(p<0.0001) such that more participants indicated the correct numeric range post-counseling.
post

Figure 4. Comparison of Miscarriage Risk Quantification Before and After Counseling
(Percentages)

80%
70%
60%
50%
40%
30%
20%
10%
0%

73%
57%

15%

17%
9%

6% 4% 3% 2%
4%
0% 2% 3% 2% 1% 0% 0% 0%

Before Counseling

After Counseling

Miscarriage Risk Perception After Genetic Counseling an
and
d Various Factors
A total of 100 participants indicated their perception of the amniocentesis miscarriage
risk after genetic counseling iin Likert scale format. Most respondents perceived the risk as
either very low (n=25) or low (n=31) after counseling (Figure 5).
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Figure 5. Perception of Miscarriage Risk After Counseling
31
(31%)
Number of Participants

35
30

25
(25%)

23
(23%)
16
(16%)

25
20

5
(5%)

15
10
5
0
Very Low

Low

Average

High

Very High

Miscarriage Risk Perception

n = 100

Miscarriage risk perception after counseling was compared to demographic factors.
None of the factors were found to be statistically significant (Table 116).

Table 16.. Comparison of Risk Perception After Counseling and Demographics
Comparison of Factors

n

p-value

Race

93

p = 0.408

Education

93

p = 0.478

Income

84

p = 0.805

Religion

90

p = 0.513
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The second portion of the survey was analyzed to examine factors potentially
influencing risk perception. Analysis revealed that there was a statistically significant
difference between miscarriage risk perception after genetic counseling and the patient’s plan
about whether or not to proceed with amniocentesis (p=0.017). In general, those who desired
to proceed with amniocentesis usually viewed miscarriage risk as lower than those who did
not elect amniocentesis (Table 17).

Table 17. Comparison of Miscarriage Risk Perception After Counseling and
Amniocentesis Plan
Amniocentesis Decision
Perception No

Yes

Unsure

Totals

Very Low

5

17

3

25

Low

10

10

8

28

Average

10

7

3

20

High

8

2

3

13

Very High

5

1

0

6

Totals

38

37

17

92

p-value = 0.017

Table 18 presents information about those who chose to proceed with amniocentesis
and their reasons for desiring amniocentesis. Participants could select as many survey items
as they desired. There was a statistically significant association between reduced miscarriage
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risk perception and patients who chose to proceed with the amniocentesis because they
needed to know whether or not the pregnancy had a chromosomal condition (p=0.015).

Table 18. Comparison of Miscarriage Risk Perception After Counseling and
Participants who Did Proceed with Amniocentesis
Comparison of Factors

n

p-value

Patient needed to know whether pregnancy had a

34

p = 0.015

The risk assoc. with Amnio is low

11

p = 0.296

Patient had Amnio in previous pregnancy

4

p= 0.429

Other reason for proceeding with Amnio

1

p = 0.553

chromosomal condition

Of those participants who decided not to proceed with amniocentesis, one item was
statistically significant: those who chose not to proceed with the amniocentesis because the
patient felt the risk of miscarriage associated with amniocentesis was too high (p=0.004)
(Table 19). Most people who indicated they did not want to proceed with amniocentesis
(n=18) for this reason perceived the risk as average (n=7) or high (n=5).
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Table 19. Comparison of Miscarriage Risk Perception After Counseling and
Participants who Did Not Proceed with Amniocentesis
Comparison of Factors

n

p-value

The risk assoc. with Amnio is too high

18

p = 0.004

Patient does not like needles

9

p = 0.131

Does not matter to patient if pregnancy has

12

p = 0.965

Patient’s friend had problem w/ Amnio

1

p = 0.670

Patient does not know what Amnio can tell

1

p = 0.670

12

p = 0.683

chromosomal condition

her
Patient does not believe pregnancy has a
problem

Finally, we examined data from those who indicated they were unsure about
amniocentesis (Table 20). None of the factors examined were found to be significant.

Table 20. Comparison of Miscarriage Risk Perception After Counseling and
Participants who were Unsure about proceeding with Amniocentesis
Comparison of Factors

n

p-value

The patient wanted to discuss

4

p= 0.813

21

p = 0.098

Amniocentesis with Husband/Partner
The patient wanted to wait for the results of
the ultrasound

43

There were a total of six prenatal counselors involved in counseling the study
participants. Risk perception after counseling was compared to the counselor who facilitated
the session. There was no difference found between counselors (p=0.723). In 13 cases, the
majority of the genetic counseling session was performed by a second year genetic
counseling student. There was no significant difference between the risk perceptions of
patients who were counseled by students instead of counselors (p=0.906).

Change in Miscarriage Risk Perception Before and After Genetic Counseling
A comparison was made between the responses of all 65 participants who indicated a
risk perception before counseling and any participant who indicated their perception after the
genetic counseling session. There was a statistically significant difference between the risk
perception before and after the genetic counseling session (p<0.0001). Additionally, analysis
using Wilcoxon signed rank test was obtained to determine the differences between the risk
perception before and after the genetic counseling session. This analysis also yielded a
statistically significant result (p=0.022). Therefore, participants perceived the miscarriage
risk associated with amniocentesis as lower after genetic counseling.
We compared the degree to which the genetic counseling session changed the way
participants perceived the miscarriage risk of amniocentesis. Figure 6 illustrates the total
change indicated by participants. A negative change indicates that the patient perceived the
risk as lower on the Likert scale after the counseling session compared to their perception
before counseling, whereas a positive change denotes that a participant felt the risk was
higher after the session. A majority of patients did not change their perception after the
counseling session (60%) or changed their perception to a slightly lower risk (26.2%).
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Figure 6. Change in Risk Perception
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We examined whether the initial risk category influenced how much the patient’s risk
perception changed. Figure 7 illustrates that, in general, women did not change their
perception regardless of category. However, of those who did change their risk perception
percep
after counseling, most generally moved to a lower level of risk perception about
amniocentesis.
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Figure 7. Degree of Change in Risk Perception Before and After Counseling
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We then compared whether women who changed their risk perception were any
an more
or less likely to be influenced by a particular factor. There were no significant findings for
f
demographic factors (Table 21
21),
), with whom the participant discussed amniocentesis (Table
22),
), or individual experience with previous genetic counseling (T
(Table 23).
). There were also
no significant factors when examining education about amniocentesis (Table 24).
2
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Table 21. Comparison of Change in Risk Perception and Demographic Factors
Comparison of Factors

n

p-value

Race

65

p = 0.706

Education

65

p = 0.798

Income

60

p = 0.850

Religion

63

p = 0.999

Table 22. Comparison of Change in Risk Perception and Patient Discussions with
Various Individuals
Comparison of Factors

n

p-value

Discuss with Dr.

45

p = 0.678

Discuss with Husband

35

p= 0.530

Discuss with Mother

20

p = 0.517

Discuss with Friend

23

p = 0.381

Discuss with Coworker

11

p = 0.941

Discuss with Sister

9

p = 0.703

Discuss with Other

7

p = 0.461

Discuss with No One

7

p = 0.538

Person made an Amnio suggestion

22

p= 0.824
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Table 23. Comparison of Change in Risk Perception and Personal Experience with
Genetic Counseling
Comparison of Factors

n

p-value

Patients w/ previous genetic counseling

11

p = 0.854

Previous GC for AMA

5

p = 0.950

Previous GC for Pos DS

1

p = 0.984

Previous GC for Fam Hx

1

p = 0.984

Previous GC for Other Indication

5

p = 0.946

Table 24. Comparison of Change in Risk Perception and Previous Education about
Amniocentesis
Comparison of Factors

n

p-value

Learned about Amnio via book

21

p = 0.335

Learned about Amnio via Pamphlet

7

p = 0.795

Learned about Amnio via Web

30

p = 0.273

Did not learn about Amnio

21

p = 0.084

Learned about Amnio via Other

3

p = 0.836
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When change in risk perception was compared to personal experience with genetic
disease, the only factor found to be significant was if the participant knew another person not
specified in the choices listed who had some sort of personal history with genetic disease
(p=0.036); (Table 25). Of the 5 who responded, three did not change their risk perception and
two increased their risk perception by one unit. Respondents tended to think that the risk
associated with amniocentesis before counseling was very low (n=2) or low (n=2). No
significance was seen between change in risk perception and personal experience with
amniocentesis (Table 26). Some p-values were not calculated due to the small sample sizes in
the groups indicated.

Table 25. Comparison of Change in Risk Perception and Personal Experience with
Genetic Disease and Birth Defects
Comparison of Factors

n

p-value

Know a friend with child/personal hx of
genetic disease

21

p = 0.214

Friend genetic disease hx

11

p = 0.254

Mother genetic disease hx

1

p = 0.984

Sister genetic disease hx

1

p= 0.984

Sister in Law genetic disease hx

1

p = 0.984

Another fam mem genetic disease hx

6

p= 0.883

Coworker genetic disease hx

2

p = 0.979

Other genetic disease hx

5

p = 0.036

7

p = 0.843

Child with birth defect
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Table 26. Comparison of Change in Risk Perception and Personal Experience with
Amniocentesis
Comparison of Factors

n

p-value

Had Amnio in Previous Pregnancy

6

p = 0.901

Previous Amnio Results were normal

5

Not calculated

Previous Amnio Results were DS

0

Not calculated

Previous Amnio Results were Tri 18

1

Not calculated

Previous Amnio results were other

2

Not calculated

1

p = 0.905

Bleeding following Amnio

1

Not calculated

Other complication following Amnio

0

Not calculated

21

p = 0.664

Friend had Amnio

16

p = 0.865

Mother had Amnio

1

p = 0.984

Sister had Amnio

1

p = 0.984

Sister in Law had Amnio

1

p = 0.702

Another Family member had Amnio

3

p = 0.991

Cowork had Amnio

5

p = 0.946

Other had Amnio

1

p = 0.720

Problem shown on friend’s Amnio

3

p = 0.416

Friend had complication after Amnio

1

p = 0.458

Complications after Amnio

Friend/Relative had Amnio
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When comparing risk perception change and pregnancy history (Table 27), two
factors were found to be significant: total number of living children (n=64; p=0.002) and
total number of still births (n=64; p=<0.001). Parity was distributed among a large number of
responses (from 0 to 5 living children), making it difficult to determine an obvious trend.
Only 2 women had a history of stillbirth.

Table 27. Comparison of Change in Risk Perception and Pregnancy and Child
Information
Comparison of Factors

n

n=0

n=1-2 n=3+

p-value

Total pregnancies

64

0

30

34

p = 0.167

Total living children

64

13

43

8

p = 0.002

Total miscarriages

64

42

18

4

p = 0.306

Total abortions/terminations

64

49

14

1

p = 0.203

Total stillbirths

64

62

2

0

p = <0.0001

Previous child with a birth

8

n/a

n/a

n/a

p = 0.652

defect
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DISCUSSION
Amniocentesis is the most common invasive procedure performed during pregnancy
(Eddleman et. al. 2006). There is a risk of miscarriage associated with amniocentesis. This
risk has been quoted as high as 1/200 (Olney, Moore, Khoury, Erickson, Edmonds, & Botto,
1995) to as low as 1/1600 (Eddleman et. al. 2006). Typically, a woman who is considering
undergoing amniocentesis will discuss the risks, benefits, and limitations with a
knowledgeable health care professional. Regardless of the specific risk of miscarriage
quoted, patients bring their own perception of the risk to the discussion. The purpose of the
current study was to determine what factors potentially anchor a woman’s perception of the
miscarriage risk.

Miscarriage Quantification and Risk Perception Before Counseling
Participants were asked to quantify the risk of miscarriage associated with
amniocentesis before they spoke with a genetic counselor. Over half of the women (57%;
n=27) responded that they believed the risk to be 1% or less while 14.8% (n=7) thought the
risk was 1.1-2% and 17% (n=8) thought the risk was 2.1-5%. The remaining 5 participants
indicated the risk as larger than these ranges. These results indicate that, while many women
may not know the exact risk of miscarriage, approximately half estimate the risk similar to
the risks quoted in the literature (ACOG Practice Bulletin No. 88: Invasive Prenatal Testing
for Aneuploidy, 2007; Eddleman et. al., 2006). However, a significant portion of women
overestimate the numeric risk associated with amniocentesis. Thus genetic counselors and
maternal fetal specialists have a role in rectifying the understanding of a substantial number
of patients.
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When asked to rate how they perceive the risk on a Likert scale of very low to very
high, most women indicated that they perceived the risk of miscarriage as average (29.7%;
n=22) to low (27%; n=20) before counseling. There was a generally normal distribution
across the risk perception scale. These results indicate that most women view amniocentesis
as a procedure with moderate to limited risk involved. Given that individuals may over- or
underestimate the importation of new information when altering their original risk
perception, understanding the risk perception brought to the genetic counseling session is
essential (Slovic, Fischhoff, & Lichtenstein, Cognitive Processes and Societal Risk Taking,
2000).

Factors that Potentially Anchor Miscarriage Risk Perception Before Counseling
When multiple comparisons were made between risk perception and various factors
postulated to cause anchoring, only two variables were statistically significant: connection to
a genetic condition and parity. Of those who indicated that they knew a person with a
personal history of a genetic disease or a child with a genetic disease (n=24), most tended to
perceive the risk of miscarriage as low (58.3%; n=14) whereas those who did not know a
friend or relative with this history were more likely to perceive the risk as average (40.4%;
n=19), (p=0.001). When compared to women who knew no one with a genetic disease,
additional analysis revealed a statistically significant difference in risk perception before
counseling and those who knew a friend (p=0.013) or another family member not specified in
previous choices (p=0.025). Women who indicated that they had this personal experience
with genetic disease had lower risk perception before counseling than those who said that
they did not know anyone with this history. Based on these results, it appears that those
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participants who had some experience with a genetic disease felt that the risk of miscarriage
associated with amniocentesis was lower than those who did not have connections to a
genetic disease. If a person has experience with a genetic disease, they are more likely to be
concerned that their own pregnancy may be affected with a genetic disease since they are
able to call specific examples of the risk to mind (Weil, 2000). Research suggests that
feelings towards the health of the pregnancy influence the decisions that women make
regarding prenatal procedures: if women feel like the pregnancy is healthy, then
amniocentesis is considered unnecessary in their minds (Markens et. al., 2010). Perhaps
having a personal representation of genetic disease anchors women to a higher perception of
the risk of genetic disease in their pregnancy, therefore causing the amniocentesis risk to
seem smaller in comparison. In turn, they may have a stronger desire to undergo prenatal
testing so that they are prepared for the potential diagnosis of a genetic condition.
There was also a statistically significant association between risk perception and the
number of living children a participant had (p=0.038). As indicated in Table 13, 45 women
had 1 or 2 living children. Women who had one living child (n=28) were more likely to view
the risk as lower than nulliparous women. Research suggests that nulliparous women are
more likely to be undecided about whether or not to proceed with amniocentesis than those
who have children (Vergani et. al., 2002). Perhaps individuals who already have a child are
less scared about losing a pregnancy as a result of an invasive diagnostic procedure.
Risk perception was stratified by a number of factors including demographics,
discussions with various individuals about amniocentesis, personal experience with genetic
counseling, previous education about amniocentesis, and personal experience with
amniocentesis, and no other factors were found to be statistically significant. Therefore, what
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anchors each person to a certain risk perception appears to be multifaceted and individual. A
person’s individual life experiences and internal assessments influence their ultimate risk
perception and these experiences are diverse (Weil, 2000). Research suggests that women
making decisions regarding prenatal testing tend to rely on highly personal opinions, such as
ethical convictions and emotional responses to invasive testing (Garcia et. al., 2007). Because
risk perception is apparently such a personalized phenomenon, it highlights the need for
highly trained health professionals such as genetic counselors to elucidate the factors for each
patient and tailor the details of the session for the patient’s individual needs.

Miscarriage Quantification and Risk Perception After Counseling
We also aimed to determine the participants’ perception of miscarriage risk after
counseling. The majority of patients perceived the risk in the correct numeric range of
between 0% and 1% after counseling (73.3%; n=66). This figure is significantly increased
from the 58.3% that indicated <1% before the genetic counseling session (p<0.0001).
Therefore, patients’ perception of the numerical risk associated with amniocentesis is more
likely to be in the correct range after counseling. While many patients had difficulty
describing the numeric risk of amniocentsis, they appeared to have a general understanding
that the risk is relatively low (1% or less). Genetic counselors use their specialized training to
ascertain the patient’s understanding of the topics discussed during the session, including the
risk associated with invasive procedures. This training and preparation allows the counselor
to provide the information in the most effective way for each patient (Weil, 2000). Because a
higher percentage of patients are correct in their risk quantification post-counseling, this may
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indicate that the counseling session is a good source of education for patients seeking
information about prenatal diagnostic procedures.
Four participants (4.4%) indicated that the risk of miscarriage associated with
amniocentesis was between 81 and 100% after counseling. One of these participants
indicated that she thought 1 out of 1000 procedures would result in a miscarriage, but also
wrote that the risk of miscarriage was 99%. Another participant indicated that she believed
50 out of 1000 procedures would end in miscarriage (5%), but converted this number to
95.2% on the survey. These cases are clear examples of non-comprehension of the
mathematical concepts needed to covert a ratio to a percentage. This finding is not
unexpected because previous studies have shown that people have difficulty with fractions
(Gates, 2004; Stevens et. al., 2008). Two other participants indicated that the risks were 90%
and 98%, with no numeric quantification for comparison. None of these participants
completed the miscarriage risk quantification question in the first portion of the survey.
Therefore, we cannot determine if the post-counseling risk quantification responses are
different than the patient’s initial belief regarding miscarriage risk before counseling.

Factors that Potentially Anchor Miscarriage Risk Perception After Counseling
There was a statistically significant association between participants’ perception of
the risk after the genetic counseling session and their plan about whether or not to proceed
with amniocentesis (p=0.017). Approximately equal numbers of participants indicated that
they would proceed with amniocentesis (n=37) and would not proceed with amniocentesis
(n=38). Participants who indicated that they would proceed with amniocentesis were more
likely to view the risk as very low (45.9%; n=17) or low (27%; n=10) whereas those
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participants who did not wish to proceed with amniocentesis were more likely to indicate
values on the higher side of the scale (p=0.004). These results indicate that women who
desire amniocentesis perceive the risk as lower than those who do not want to undergo the
procedure. If a woman has decided she wants to proceed with amniocentesis, she may want
to justify this decision in her mind by indicating that she perceives the risk as lower than a
woman who has decided not to undergo the procedure. When decisions are made, individuals
often must provide justification for those decisions due to pressures from society, authority,
or self (Huber, Bar, & Huber, 2009). In the case of amniocentesis, a woman may have to
provide justification of her decision to herself, her doctor, her family, or her spouse.
Women who stated that they wanted to proceed with amniocentesis because they
wanted to know whether or not the pregnancy was affected with a chromosomal problem
were significantly more likely to perceive the miscarriage risk associated with amniocentesis
as low (p=0.015). This finding may be further confirmation that certain aspects of a person’s
life experiences are used during risk perception and decision-making (Slovic, The Perception
of Risk, 2000). Perhaps some women anchor to uncertainty of aneuploidy in the pregnancy
and minimize the risk associated with amniocentesis. Further studies are needed to examine
how much weight individuals place on certain risks in the decision-making processes.

Changes in Miscarriage Risk Perception
A large number of participants’ view of the risk of amniocentesis remained
unchanged after genetic counseling (60%; n=39). Therefore while significantly more
participants knew the true numeric risk (p<0.0001), their perception of the risk remained
unchanged. This finding is particularly interesting because it appears that the genetic
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counseling session has little effect on the perception of risk of many patients, even though
much of the session is typically focused on a discussion of aneuploidy, amniocentesis, and
miscarriage risk. This finding may indicate that many patients’ feelings about the miscarriage
risk and amniocentesis procedure are rigid before they speak with a counselor, and those
discussions with the counselor have little to no influence on their final perception. Perhaps
patients use the information that the counselor provides as further “proof” of the acceptability
of their decision. For example, if the patient perceives the risk of miscarriage associated with
amniocentesis as high and does not feel that they want to proceed with the amniocentesis,
they may focus on the possibility of miscarriage due to the procedure during the session as
further justification for their perception, whereas those who are more anxious about the
possibility of a chromosomal condition may choose to interpret that risk as high and the risk
of amniocentesis as low. Ultimately, participants appeared to be anchored to a prior concept
regarding the risk (Tversky & Kahneman, 1974) and the genetic counseling session had
minimal effect on this anchor for the majority of patients in this study.
Participants whose risk perception changed after the counseling session were
significantly more likely to reduce their risk perception: of those who changed their
perception (n=26), 76.9% (n=20) lowered their risk perception after counseling (p<0.0001).
Therefore, when the counseling session had an influence on the patient’s risk perception, it
tended to lower the patient’s perception of the risk. Perhaps the risk that is quoted in the
genetic counseling session is smaller than the one that the patient is anticipating, which
causes the patient’s perception to be lower after counseling. Further study is needed to
investigate the cause of the lowered risk perception since few factors were found to be
associated with change.
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When comparing whether women who changed their risk perception were more likely
to be influenced by a certain factor, three factors were found to be statistically significant:
whether or not the participant knew someone besides the relationships listed who had a
personal history or child with a genetic condition (n=5; p=0.036), total number of living
children (p=0.002), and total stillbirths (n=2; p<0.0001). However, given the small sample
sizes it is difficult to determine whether or not these significant factors are true or due to
chance.

Strengths and Limitations of the Current Study
The relatively large and diverse sample set in this study allows for reasonable
conclusions to be drawn that are likely applicable to other patient populations around the
country. Given that 35.1% of participants were Caucasian, 26.1% were Hispanic, and 24.3%
were African American and we were still unable to find significant differences between the
racial groups that were anchoring risk perception, it seems that risk perception is
individualized by person and not likely due to cultural background. Another strength of the
study was the capture of risk perception both pre- and post-counseling. There is limited data
regarding change in miscarriage risk perception associated with amniocentesis. This study
shows that when risk perception is changed, it tends to be decreased, but that risk perception
is unchanged for many seeking genetic counseling.
There were also several limitations of this study. The data was gathered via a selfadministered questionnaire, which caused participants to interpret questions without any
guidance. Sixty-six participants left the quantification question blank on the first portion of
the survey and 14 left the question blank on the second portion. This may be due to the
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intimidation individuals feel regarding mathematical concepts or because they were afraid of
being incorrect. Future studies may wish to explore alternate methods of assessing numeric
risk to improve participation. In addition, we did not account for the number of patients who
refused to participate in the study; therefore, those who completed the survey may have been
motivated to do so and may bias the results of the study. This study was also conducted at
multiple satellite clinics in the Houston area, each of which is staffed by different personnel
responsible for survey distribution. Lack of consistency of survey distribution may have
biased who received the survey and what percentage of the patient population of a given
clinic completed the questionnaire.
As women who were counseled with use of an interpreter were excluded, further
study may be needed in other populations that may be seen for genetic counseling, such as
non-English-speaking patients who may be less familiar with amniocentesis. It would be
useful to confirm the results of this study in other populations to determine if the anchoring
effects are more homogenous.

Conclusion
In conclusion, this study aimed to determine how prenatal patients perceived the risk
of miscarriage associated with amniocentesis before and after a genetic counseling session.
The study also attempted to determine what factors anchor a woman’s perception of that risk.
In general, most women perceived the risk as low or average pre-counseling and were likely
to indicate the risk of amniocentesis as <1% risk. A significantly higher percentage of
patients correctly identified the numeric risk as <1% post-counseling when compared to precounseling (p<0.0001). However, the study found that the majority of patients’ feeling about
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the risk perception did not change after the genetic counseling session (60%), regardless of
how they perceived the risk before discussing amniocentesis with a genetic counselor. Of
those whose perception changed, it was significantly lower post-counseling (p<0.0001). Few
factors were found to influence risk perception in a significant manner. One significant factor
was that those with a friend or relative with a personal or family history of a genetic disorder
were more likely to perceive the risk as low (p=0.001). In addition, having a child already
was likely to make a woman perceive the risk as low (p=0.038). The lack of overall
consistent significant factors may reinforce the importance of genetic counseling to elucidate
individual concerns.

61

Appendix A
University of Texas-Health Sciences Center Houston
Risk Perception Associated with Amniocentesis
Amniocentesis Information:
The purpose of this survey is to understand the thoughts of pregnant women about the risk
associated with amniocentesis. An amniocentesis (sometimes called the needle test) is a
procedure used to tell if the baby has certain genetic conditions, such as Down syndrome.
During an amniocentesis, the doctor uses a needle to remove a few teaspoons of fluid from
the water sac.

1. Was this the first time you heard of an amniocentesis?
Yes (If yes, proceed to question #18)
No
2. If 1,000 women have an amniocentesis, how many of the 1,000 will have a
miscarriage due to the amniocentesis?
_____________ out of 1,000 women will have a miscarriage after an
amniocentesis
( if you would prefer, you can provide a percentage:
__________%)
3. How do you feel about the risk of miscarriage from amniocentesis? It is:

Very Low

Low

Average

High

Very High

4. Who have you talked to about the amniocentesis? (Check all that apply)
My doctor
My friends
My husband/partner
My co-workers
My mother
My sister
No one (Please skip to question #6)
Other: ___________________________________
5. If you talked with someone about the amniocentesis, did they suggest that you get the
amniocentesis?
Yes
No
They did not give a suggestion
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6. Where have you read information about amniocentesis? (Check all that apply)
Book (ex. What To Expect When You’re Expecting)
Pamphlet
Internet website
None
Other: ______________________________________________________
7. Have you ever had an amniocentesis performed in a previous pregnancy? (Check one)
Yes
No (If no, please skip to question #11)
I don’t know
8. If yes, how many times have you had an amniocentesis performed in a previous
pregnancy? (Check one)
One
Two
Three or more
9. What did the amniocentesis results show? (Check all that apply)
No problem (normal chromosomes)
Down syndrome
Trisomy 18
Trisomy 13
Extra or missing sex chromosome problem (such as Turner or Klinefelter
syndrome)
Neural tube/open spine defect (spina bifida)
I don’t know
Other: ___________________________________________________
10. Did you have any complications after the amniocentesis?
Yes (if yes, please check which complications below)
Bleeding
Fluid Leakage
Fever
Miscarriage
Other:
___________________________________________________
No
11. Do you have friends or relatives who have had the amniocentesis?
Yes (if yes, please check who below)
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Friend
Mother
Sister
Sister-in-law
Another family member
Coworker
Other: _________________________________________
No (If no, please skip to question #14)
I don’t know
12. Did the amniocentesis show any problems with their baby?
Yes
No
I don’t know
13. Did your friend/relative/coworker have any complications from the amniocentesis?
Yes (if yes, please check which complications below)
Bleeding
Fluid Leakage
Fever
Miscarriage
Other: _______________________________________________
No
14. Do you have any friends/relatives/coworkers who have a child or a personal history
of a genetic disorder or birth defect?
Yes (if yes, please check who below)
Friend
Mother
Sister
Sister-in-law
Another family member
Coworker
Other: _______________________________________________
No
15. What genetic disorder or birth defect does your friend/relative/coworker have?
Please describe:
___________________________________________________
16. Have you ever had genetic counseling before today?
Yes
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If yes, when did you have genetic counseling (year):
________________
If yes, for what reason did you have genetic counseling:
Advanced Maternal Age (over 35)
Positive blood test for Down syndrome or trisomy 18
Positive blood test for open neural tube defect/spina bifida
Family history of a genetic condition
Other: ______________________________________
No
17. Have any of your children been diagnosed with a genetic disorder or a birth defect
(such as cystic fibrosis, sickle cell disease, heart defect, cleft lip, Down syndrome,
etc)? (Check one)
Yes - please specify the disorder or birth defect: _____________
No
I don’t have any children

Demographics:
18. How old are you? _______________ years old
19. What is your race/ethnic background? (Check one)
African-American
Hispanic
Asian
Caucasian
Other: ___________________________________
20. What is the highest grade you have completed ?(Check one)
Some high school
High School
Some college
College
Graduate School
21. What is your total combined annual household income (check one):
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< 30,000
30,000 – 60,000
60,000 – 100,000
> 100,000
22. What is your religious affiliation (Check one)
Protestant
Catholic
Jewish
Muslim
Buddhist
Hindu
None
Other: ___________________
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Appendix B
University of Texas-Health Sciences Center Houston
Risk Perception Associated with Amniocentesis
During the genetic counseling session, the genetic counselor discussed the amniocentesis
with you.
1. If 1000 women have an amniocentesis, how many of the 1000 will have a miscarriage
due to the amniocentesis?
_____________ out of 1000 women will have a miscarriage after an amniocentesis
(If you would prefer, you can provide a percentage: __________%)

2. How do you feel about the risk of miscarriage from amniocentesis? It is:

Very Low

Low

Average

High

Very High

3. Is the amniocentesis is something that you plan to do in this pregnancy?
Yes (if yes, please check all that apply)
I need to know if the baby has a genetic condition like Down
syndrome before birth
I think that the risk associated with amniocentesis was low.
I had one in a previous pregnancy and everything was fine
Other:
__________________________________________________
No (if no, please check all that apply)
The risk of miscarriage is too high
I do not like needles
It doesn’t matter to me if the baby has a genetic condition like Down
syndrome
I had a friend/relative with a problem after amniocentesis
I don’t know what the amniocentesis will tell me about the baby
I don’t think that my baby has a problem
Other: __________________________________________________
Unsure/Not at this visit (if unsure, please check all that apply)
I need to speak to my husband/partner
I want to wait and see if there are any abnormalities on ultrasound
first
Other: __________________________________________
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Appendix C
University of Texas-Health Sciences Center Houston
Influence of Anchoring on Miscarriage Risk Perception Associated with Amniocentesis

1. Risk of miscarriage from amniocentesis quoted to patient:
1 in 200
1 in 250
1 in 300
1 in 500
_______________

other:

2. Which of the following factors (if any) do you feel influenced the patient’s decision
regarding amniocentesis:
(check all that apply)
Risk of miscarriage
Prior amniocentesis
Prior miscarriage
Prior child with a birth defect/genetic condition
Family history of prior child with a birth defect/genetic condition
Information patient read about amniocentesis
Religious conviction
Use of needle
Opinion of:
Friend
Mother
Father
Sibling
Another family member
Coworker
Patient’s physician
Other:________________________
Other: __________________________________________
3. Is the patient having amniocentesis?
Yes (if yes, due to)
She expressed a need to know if the baby has a genetic condition
before birth
She felt that the risk associated with amniocentesis was low.
She had an amniocentesis previously
Other: ______________________________________________
No (if no, due to)
The risk of miscarriage is too high
Does not like needles
It doesn’t matter to the patient if the baby has a chromosome
problem like Down syndrome
She had a friend/relative with a problem after amniocentesis
She did not understand the information about amniocentesis
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She did not believe that the baby had a chromosome problem
Other:
__________________________________________________
Unsure/Not at this visit (if unsure, due to)
She needed to speak with her husband/partner
She wanted to see if there are any abnormalities on ultrasound first
Other: ________________________________________________
4. Counselor for the session:
Carter
Czerwinski
Hoskovec
Singletary
Sullivan
Wilson
5. Did the genetic counselor perform the majority of the session?
Yes
No (if no, then who)
First year genetic counseling student
Second year genetic counseling student
Resident
Fellow
6. Were there any other factors that you felt influenced the session? If so, please
comment:
_____________________________________________________________________
_____________________________________________________________________
_____________________________________________________________________
_____________________________________________________________________
_____________________________________________________________________
_______________
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Appendix D
University of Texas-Health Science Center Houston
Risk Perception Associated with Amniocentesis
Dear Potential Study Participant,
You are being invited to take part in a research study called Influence of Anchoring on
Miscarriage Risk Perception Associated with Amniocentesis. We are interested in what
factors affect a woman’s perception of the miscarriage risk associated with a test called
amniocentesis. The people in charge of this research project are Regina Nuccio and Claire
Singletary at the University of Texas Medical School Houston. For this research study, they
will be called the Principal Investigators, or PIs.
Your decision to join this research study is voluntary. You may refuse to take part, or choose
to stop taking part at any time. Your decision about participation in this study or answering
questions will not change the care or services that you receive from the University of Texas
Health Science Center Houston.
This research study involves taking an anonymous survey to look at factors that affect what
people think about the risk of miscarriage risk associated with amniocentesis. Amniocentesis
is a prenatal procedure that involves inserting a needle into a woman’s abdomen in order to
remove 4 teaspoons of liquid from the sac that the baby floats in. A test is then run on the
cells in this liquid that can tell if the baby has a chromosome problem, such as Down
syndrome.
If you agree to join this study, you will be given the survey in two parts. The first part will be
given to you before your genetic counseling session. This part of the survey includes
questions about people you may or may not have discussed the amniocentesis with as well as
personal, medical, family, and pregnancy history. The second part will be given to you after
the genetic counseling session while you are waiting for your ultrasound. This part of the
survey is shorter than the first and will ask you some of the same types of questions as the
first part. Both parts of the survey will take about 10 minutes to complete. Your responses
will be confidential and will be viewed only by the researchers involved in the study. You
will not be asked to include your name or any information that will personally identify you.
After completing the survey, it will be placed in a sealed envelope for the Principal
Investigators.
Although the results of this study will be useful for doctors, other health professionals and
future pregnant women, there may be no direct benefit to you for participating in this study.
There is no physical danger in joining this study. Some of the questions on the survey may
make you feel uncomfortable. You can refuse to answer or skip any questions or stop taking
the survey at any time. If you decide to participate in the study, it is very important that you
answer as honestly as you can to the questions that are asked.
It will not cost you anything to join this study. You will not be paid to complete the survey.
All surveys will be kept in a secured area that is only accessible to the research staff. You
will not be personally identified in any reports or publications of this study.
If you have any questions or would like more information, please contact Regina Nuccio, BS
or Claire Singletary, MS, CGC at (713) 500-5760. If you would like to withdraw from the
study at any time, please contact Ms. Nuccio or Ms. Singletary at the above number.
If you are willing to take part in our study, please complete and return the survey in the
enclosed envelope to the front desk personnel or genetic counselor.
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Thank you very much for considering this invitation to participate in our study.
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